Oncology

Oncology is the most active new drug development area in the world, and GCCL has the most extensive analytical experience in this area. We provide comprehensive services and reliable data to support optimal decision-making in the drug development process.

Cell & Gene Therapy

GCCL has experience in analysis related to the development of CAR-T and CAR-NK treatment, and provides bio-analysis services at all stages of cell and gene therapy development, including immunogenicity and PK/PD analysis.

Central Nervous System

GCCL provides mass spectrometry and ultra-sensitive immunoassay services in the field of the central nervous system, as well as biomarker and PK analysis services for optimal research.

COVID-19

Infectious Disease

GCCL provides project-customized services that are bio logistics, and PBMC Isolation, and has a variety of high-quality analysis platforms and bio-safety facilities (BL2/BL3) suitable for analysis of clinical trial samples for vaccines, treatments, and in vitro diagnostic devices for viral and bacterial infectious diseases such as COVID-19, Influenza, Tuberculosis, NASH, and Hepatitis.